Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients
Keywords: HDL; Niacin; Fenofibrate; Preβ1-HDL; PON1; PON3; CETP; LCAT; PAF-AH; Type 2 diabetes; HDL particle size; Nuclear magnetic resonance;